Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: J Stroke Cerebrovasc Dis. 2015 Jul 4;24(9):1991–1997. doi: 10.1016/j.jstrokecerebrovasdis.2015.04.044

Table 1.

Baseline Characteristics (N=4,008)

Characteristic ECG-LVH
(n=136)
No ECG-LVH
(n=3,872)
P-value* Echo-LVH
(n=208)
No Echo-LVH
(n=3,800)
P-value*
Age, years
 65-70 (%) 45 (33) 1,736 (45) 108 (52) 1,673 (44)
 71-74 (%) 35 (26) 911 (24) 44 (21) 902 (24)
 75-80 (%) 37 (27) 866 (22) 46 (22) 857 (23)
 >80 (%) 19 (14) 359 (9.3) 0.032 10 (4.8) 368 (10) 0.040
Male (%) 36 (26) 1,609 (42) 0.0004 84 (40) 1,561 (41) 0.84
High school or less (%) 75 (55) 2,174 (56) 0.82 138 (66) 2,111 (56) 0.0023
Income <$25,000 (%) 84 (62) 2,343 (61) 0.77 138 (66) 2,289 (60) 0.079
Body mass index, mean (SD), kg/m2 26 (3.5) 26 (4.0) 0.23 31 (3.9) 26 (3.8) <0.0001
Current or former smoker (%) 52 (38) 2,084 (54) 0.0003 103 (50) 2,033 (54) 0.26
Diabetes (%) 27 (20) 526 (14) 0.037 60 (29) 493 (13) <0.0001
Atrial fibrillation (%) 16 (12) 180 (4.7) 0.0002 21 (10) 175 (4.6) 0.0003
Systolic blood pressure, mean (SD), mm Hg 150 (22) 138 (19) <0.0001 143 (20) 138 (20) 0.0002
Total cholesterol, mean (SD), mg/dL 216 (40) 213 (39) 0.31 212 (42) 213 (39) 0.42
HDL-cholesterol, mean (SD), mg/dL 51 (16) 54 (16) 0.015 47 (12) 55 (16) <0.0001
Antihypertensive medication use (%) 87 (64) 1,623 (42) <0.0001 134 (64) 1,576 (41) <0.0001
Statin use (%) 2 (1.5) 76 (2.0) 0.68 4 (1.9) 74 (2.0) 0.98
Aspirin use (%) 46 (34) 1,264 (33) 0.77 80 (38) 1,230 (32) 0.068
Cardiovascular disease (%) 42 (31) 705 (18) 0.0002 75 (36) 672 (18) <0.0001
*

Statistical significance for continuous data was tested using Wilcoxon rank-sum procedure and categorical data was tested using the chi-square test.

ECG-LVH=electrocardiographic left ventricular hypertrophy; echo-LVH=echocardiographic left ventricular hypertrophy; HDL=high-density lipoprotein; SD=standard deviation.